Disposition of 15064 shares by Lake Ryan David of Baudax BioInc at 1.14 subject to Rule 16b-3
| BXRXDelisted Stock | USD 0.76 0.06 7.32% |
Slightly above 62% of Baudax Bio's investor base is looking to short. The analysis of current outlook of investing in Baudax Bio suggests that many traders are alarmed regarding Baudax Bio's prospects. Baudax Bio's investing sentiment can be driven by a variety of factors including economic data, Baudax Bio's earnings reports, geopolitical events, and overall market trends.
Baudax |
Filed transaction by Baudax BioInc Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Baudax Bio Fundamental Analysis
We analyze Baudax Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baudax Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baudax Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Baudax Bio is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Baudax Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Baudax Bio stock to make a market-neutral strategy. Peer analysis of Baudax Bio could also be used in its relative valuation, which is a method of valuing Baudax Bio by comparing valuation metrics with similar companies.
Peers
Baudax Bio Related Equities
| BDRX | Biodexa Pharmaceticals | 14.00 | ||||
| DRMA | Dermata Therapeutics | 2.73 | ||||
| QNRX | Quoin Pharmaceuticals | 1.69 | ||||
| PALI | Palisade Bio | 1.65 | ||||
| NRBO | Neurobo Pharmaceuticals | 0.43 | ||||
| ALLR | Allarity Therapeutics | 0.90 | ||||
| ENSC | Ensysce Biosciences | 2.00 | ||||
| CYTO | Altamira Therapeutics | 4.76 | ||||
| VRAX | Virax Biolabs | 4.83 | ||||
| CNSP | Cns Pharmaceuticals | 8.33 | ||||
| WINT | Windtree Therapeutics | 13.11 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Baudax Stock
If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |